Telix at SUO 2025

Join Telix at the 2025 Society of Urologic Oncology (SUO) Annual Meeting, one of the world’s leading international congresses dedicated to advances in urologic cancer care. Telix will be showcasing its Phase 3 precision imaging and therapeutic trials in prostate and kidney cancer.